Lloyd Mitchell Segal
CIK 1477123 · PRESIDENT AND CEO · last filed 2026-01-12
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$475.3K
Companies
3
Total Filings
38
Lifetime Open-Market Net
-$1.89M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AKTS | Director | 19,631 | $24.21 | $475.3K | $0 | 1 | 2026-01-12 |
| Repare Therapeutics Inc. (RPTX) Delisted | PRESIDENT AND CEO | 231,952 | $2.65 | $614.7K | -$1.89M | 17 | 2025-03-14 |
| Bausch Health Companies Inc. (BVF) Delisted | Director | — | — | — | $0 | 4 | 2010-07-07 |
Recent Filings · Page 2 of 4
38 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-01-20 | Repare Therapeutics Inc. (RPTX) Delisted | Exer (M) | — | $0 | EDGAR |
| 2021-06-30 | Repare Therapeutics Inc. (RPTX) Delisted | Sell (S) | −1,542 | -$54.9K | EDGAR |
| 2021-06-10 | Repare Therapeutics Inc. (RPTX) Delisted | Sell (S) | −1,576 | -$55.2K | EDGAR |
| 2021-06-07 | Repare Therapeutics Inc. (RPTX) Delisted | Mixed | −36,000 | -$1.27M | EDGAR |
| 2021-05-21 | Repare Therapeutics Inc. (RPTX) Delisted | Sell (S) | −3,770 | -$132.1K | EDGAR |
| 2021-05-20 | Repare Therapeutics Inc. (RPTX) Delisted | Sell (S) | −5,600 | -$196.2K | EDGAR |
| 2021-04-19 | Repare Therapeutics Inc. (RPTX) Delisted | Sell (S) | −5,512 | -$193.0K | EDGAR |
| 2021-02-10 | Repare Therapeutics Inc. (RPTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-06-25 | Repare Therapeutics Inc. (RPTX) Delisted | Buy (P) | +5,000 | $100.0K | EDGAR |
| 2020-06-19 | Repare Therapeutics Inc. (RPTX) Delisted | Grant (A) | — | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.